Landmark study of personalized therapy may lead to a “flood of new agents”
MD Anderson News Release 05/31/11
A lymphoma vaccine uniquely tailored for each patient extends disease-free survival by 14 months, with signs of an even better response for patients with a specific biological marker, a team led by scientists at The University of Texas MD Anderson Cancer Center reported today in the online version of Journal of Clinical...
Phase II study shows 61 percent response rate for patients with resistant or recurrent disease
MD Anderson News Release 05/23/11
Appointment puts Klein in line to become chair in 2014
MD Anderson News Release 5/19/2011
Effective Sept.1, business entrepreneur...
MD Anderson study first to compare benefits of mind-body practices to simple stretching exercises
MD Anderson News Release 05/18/11
For women with breast cancer undergoing radiation therapy, yoga offers unique benefits beyond fighting fatigue, according to new research from The University of Texas MD Anderson Cancer Center.
While simple stretching exercises improved fatigue, patients who participated in yoga that...
MD Anderson Experts Recommend Getting Vitamin D from Sources Other than Sunlight
MD Anderson News Release 05/11/11
<...Tool may one day be used to guide patients’ treatment with standard therapy alone, or personalized clinical trial upfront
MD Anderson...
UT MD Anderson-led team finds evidence that WWP2 subverts a brake on cell growth
MD Anderson News Release 05/03/11
A protein...